Investigation of the HSPG2 Gene in Tardive Dyskinesia - CORE

Sanitaria de Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain; almudena.gil@usc.es (A.G.-R.); sheila.recarey.rama@usc.es (S.R. ...







Realizing the Promise of Pharmacogenomics - Georgetown University
Sustained responders exhibited 112 distinct genes and regulatory patterns linked to ketamine efficacy, with key biomarkers including DENN domain containing 5B ( ...
Molecular genetics of substance use disorders - DRUGZ
Tardive dyskinesia (TD) is a movement disorder that may develop in schizophrenia patients being treated long-term with antipsychotic medication.
Pharmacogenomic Study of SARS-CoV-2 Treatments
Based on present knowledge, in this work we review the importance of the pharmacogenetic tests in the treatment with antipsychotic drugs. Many associations have ...



Autres Cours:

Susie H - University of Southern California